The Claim
Non-selective inhibition of the myostatin receptor pathway elevates low-density lipoprotein cholesterol levels in humans.
Source: Everyone is About to Become Lean and Muscly (new evidence)
What the research says
Not yet evaluated
We are still looking at what the research says.
Supports
0score
Challenges
0score
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Cause and effect
0 studies reviewed
In plain English
Blocking the myostatin receptor pathway in humans increases levels of low-density lipoprotein cholesterol.
See the scientific wording
Non-selective inhibition of the myostatin receptor pathway elevates low-density lipoprotein cholesterol levels in humans.
Related videos
Score breakdown, mechanism chain, raw evidence, ideal studies needed
Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.